Company intelligence / Profile preview
Ningxia Taiyicin Biotech
- Ownership
- Private
- Development stage
- Commercial
Overview
Ningxia Taiyicin Biotech is a large-scale Chinese pharmaceutical company specializing in the research, development, production, and sales of active pharmaceutical ingredients (APIs), especially antibiotics such as erythromycin thiocyanate, lincomycin hydrochloride, azithromycin dihydrate, clarithromycin, tylosin tartrate. The company holds GMP certification from China’s agriculture administration and international quality certifications including CEP and USFDA for several products. Its products are sold to over 120 countries.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small moleculeAntibioticPeptides
- Industry
- Chemicals & Materials
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Ningxia Taiyicin Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ningxia Taiyicin Biotech.